Tag Archives: Labiotech

Idorsia leaps 45% in market debut; Actelion spinoff looks like sure bet with J&J backing to boot. How to invest.

Idorsia Ltd. (Allschwil CHE), the research-based spin-out from Actelion following the latter’s $30 billion acquisition by Johnson & Johnson (New Brunswick NJ), which has now been completed, started trading on… Read more »

Carmat Jumps after First Implantation of Bioprosthetic Artificial Heart; Says Device May Last “For Years.”

Carmat SA (Villacoublay FRA) announced that its artificial heart has been implanted for the first time in an important clinical study that may lead to European regulatory approval. It is similarly… Read more »